Supriya Lifescience Limited IPO Details

Supriya Lifescience Limited IPO Details

How to Open Demat Account, Demat Account

Company All Details

Founded

2008

Managing Director

Managing Director of The Company, Namely Satish Waman Wagh.

Company Promoters:

Promoters of the Company, Satish Waman Wagh.

About the company.

The Company was incorporated as ‘Supriya Lifescience Limited’ pursuant to a certificate of incorporation dated March 26, 2008 issued by the Registrar of Companies, Maharashtra at Mumbai (“RoC”), upon the conversion of ‘M/s Supriya Chemicals’, a partnership firm, into a public limited company, in accordance with the provisions of Part IX of the Companies Act, 1956. The Company commenced operations pursuant to a certificate for commencement of business dated April 1, 2008 issued by RoC. For further details, including details relating to changes in the registered office see “History and Certain Corporate Matters” on page 154.

Supriya Lifescience Limited is one of the key Indian manufacturers and suppliers of active pharmaceutical ingredients (“APIs”), with a focus on research and development. As of October 31, 2021, it has niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic. It has consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-50% and 60-65%, respectively, of the API exports from India, between Fiscal 2017 and 2021. It was among the largest exporters of Salbutamol Sulphate in India contributing to 31% of the API exports from India in FY 2021 in volume terms (Source: CRISIL Report).

Objects Of The Offer:

• Funding capital expenditure requirements of our Company: 92.3 Cr.
• Repayment and/or pre-payment, in full or part, of certain borrowings availed by our Company: 60 Cr.
• General corporate purposes.
  Further, the company expects to receive the benefits of listing of the Equity Shares including to enhance its visibility and the brand image among its existing and potential customer

Supriya Lifescience Limited IPO Details:

Issue Amount : Upto Rs 700 Cr
Post Issue Implied Market Cap: Upto ₹2,205 Cr at Upper band
Total shares on offer : Upto # 25,547,445 Equity Shares
Face Value : ₹2 per share
Price Band : ₹262 to ₹274
Lot Size : 54 shares
IPO Registrar : Link Intime India Private Limited.

Supriya Lifescience Limited IPO Timeline, IPO Open Date, Listing Date, Refund Date

Offer Breakup

Important Financial Data:

For the year/period ended (₹ in Crore) Last Three Year

Prospectus Document:

Download RHP File

Download DRHP File

What is Supriya Lifescience IPO?

Issue Amount : Upto Rs 700 Cr.

Supriya Lifescience IPO Open?

16 Dec 2021 to 20 Dec 2021.

Registered Office

Registered and Corporate Office:
207/208, Udyog Bhavan, Sonawala Road,
Goregaon – East, Mumbai – 400063, Maharashtra, India;
Tel: +91-22-40332727
Contact Person: Shweta Shivdhari Singh,
Company Secretary and Compliance Officer;
Tel: +91-22-40332727;
E-mail: cs@supriyalifescience.com
Website: www.supriyalifescience.com;
Corporate Identity Number: U51900MH2008PLC180452

How to apply on Zerodha, Supriya Lifescience IPO through Zerodha?

Zerodha customers can apply online in Tarsons Products IPO using UPI as a payment gateway. Zerodha customers can apply in Supriya Lifescience IPO by login into Zerodha Console (back office) and Select an I.P.O application form.

Steps to apply in Supriya Lifescience IPO through Zerodha.
1. Visit the Zerodha website or Kite App and login to Zerodha.
2. Go to Console area and click the IPOs link.
3. Go to the ‘ Supriya Lifescience IPO’ row and click the ‘Bid’ button.
4. Enter your UPI ID, Quantity, and Price.
5. ‘Submit’ IPO application form.
6. After Successfully submitting application, Visit the UPI App and approve the mandate (Enter your UPI pin & pay the ipo amount)
7. IPO application is complete you can chek status on zerodha console.